Cafepharma Today

June 9 2025 - Merck claims study success with PCSK9 cholesterol pill
Merck claims study success with PCSK9 cholesterol pill
FDA limits Merck's Keytruda, Bristol Myers' Opdivo in stomach cancer
Drug imports plummeted in April despite tariff threat
Sanofi starts shipping RSV drug early as rival nears market
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva investing $19M in CureTech, aiding in R&D
Yahoo/AP
Wednesday, September 14, 2011 - 10:46am
tags:
Teva Pharmaceuticals, R&D, CureTech
Merck Sticks With The Partnership Model In China For R&D
Seeking Alpha
Wednesday, September 14, 2011 - 10:44am
tags:
Merck, R&D, China
Pfizer Delays Formula Unit Sale to Explore Spinoff
Bloomberg
Wednesday, September 14, 2011 - 10:23am
tags:
Pfizer, infant formula, M&A, Danone SA, Abbott Laboratories, Nestle
Lilly invests $30M in chronic-disease partnerships
Yahoo/AP
Wednesday, September 14, 2011 - 10:22am
tags:
Eli Lilly, Brazil, Mexico, South Africa
Johnson & Johnson Gets CRL on Simponi
Yahoo/Zacks.com
Wednesday, September 14, 2011 - 10:21am
tags:
JNJ, Simponi, Merck, psoriatic arthritis
Abbott Laboratories is Dealing to Flank Other Drug Makers
Yahoo/Wall St. Cheat Sheet
Wednesday, September 14, 2011 - 10:19am
tags:
Abbott Laboratories, Amgen, Bristol-Myers Squibb
Novartis Drug Cleared in EU for SEGA
Yahoo/Zacks.com
Wednesday, September 14, 2011 - 10:17am
tags:
Novartis, Europe, subependymal giant cell astrocytomas, SEGA, Pfizer, ONYX Pharmaceuticals
Is Abbott Laboratories' Cash Machine Slowing Down?
Motley Fool
Wednesday, September 14, 2011 - 10:16am
tags:
Abbott Laboratories
New PDUFA Changes FDA Panels: Mike Explains
Pharmalot
Tuesday, September 13, 2011 - 2:24pm
tags:
FDA, PDUFA, advisory panels
Lilly, Amylin, Merck Diabetes Drug Risks Highlighted
Minyanville
Tuesday, September 13, 2011 - 2:18pm
tags:
Merck, Eli Lilly, Amylin, diabetes, Bydureon, Alkermes, Victoza, Byetta, Novo Nordisk
Novartis Aims to Beat $1.9B in Cost Savings By Year's End
Motley Fool
Tuesday, September 13, 2011 - 2:16pm
tags:
Novartis, CIBA Vision, Alcon
Pfizer extends tender offer for Icagen shares
Yahoo/AP
Tuesday, September 13, 2011 - 2:15pm
tags:
Pfizer, Icagen, tender offer
Pfizer, Bayer others settle drug price allegations in Pa.
Bizjournals.com
Tuesday, September 13, 2011 - 2:15pm
tags:
Bayer, Pfizer, Pennsylvannia, drug pricing
What's Bad For Bisphosphonates Is Good For Emisphere
Seeking Alpha
Tuesday, September 13, 2011 - 10:18am
tags:
Emisphere, bisphosphonates, Amgen, Merck, Novartis, Roche, Sanofi
Novo Says More Patients Helped by Victoza When Diabetes Is Tackled Early
Bloomberg
Tuesday, September 13, 2011 - 10:16am
tags:
Victoza, diabetes, Novo Nordisk
Biocon Rises After Starting Manufacture of Lipitor Ingredients
Bloomberg
Tuesday, September 13, 2011 - 10:16am
tags:
Biocon, Lipitor, Pfizer, Malaysia
Medivation Remains Neutral
Yahoo/Zacks.com
Tuesday, September 13, 2011 - 10:15am
tags:
Medivation, JNJ, Pfizer, dimebon, Alzheimer's disease, prostate cancer, MDV3100
Is United Therapeutics Earning Its Keep?
Motley Fool
Tuesday, September 13, 2011 - 10:13am
tags:
United Therapeutics, Pfizer, Teva Pharmaceuticals, GSK
Lilly/Amylin diabetes drug shows promise
Yahoo/InvestorsBusinessDaily
Tuesday, September 13, 2011 - 10:12am
tags:
Eli Lilly, Amylin, Bydureon, diabetes
Commonly Used Pain Pills Increase Kidney Cancer Risk in Study
Bloomberg
Monday, September 12, 2011 - 5:48pm
tags:
kidney cancer, ibuprofen, JNJ, Pfizer, Bayer, naproxen

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine and Aging: Is There Anything to It?
In the Pipeline
Cleaning Up the Medical Literature
In the Pipeline
Not One of Your Easy Crystals
In the Pipeline
The Continuing Crisis, Part XV: The Horrendous Trump Budget
In the Pipeline
Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.